Related Experiment Video
Updated: Jul 14, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
The challenges of vaccine responses in early life: selected examples
1Centre for Vaccinology and Neonatal Immunology, University of Geneva, CMU, 1 Michel Servet, 1211 Geneva 4, Switzerland. Claire-Anne.Siegrist@medecine.unige.ch
Insights
Developing effective early-life vaccines is challenging due to immature neonatal immune responses and maternal antibodies. Novel strategies like priming and boosting are key to protecting infants from infectious diseases.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Neonatal immune systems exhibit distinct differences from adult responses in both humoral and cell-mediated immunity.
- Infants show poor responses to T-independent antigens and weaker antibody production to T-dependent antigens.
- Maternally derived antibodies can inhibit effective early-life vaccination responses.
Purpose of the Study:
- To address the challenge of developing vaccines for early-life protection.
- To understand the immunological barriers to neonatal vaccination.
- To explore novel vaccination strategies for infants.
Main Methods:
- Comparative analysis of adult and neonatal immune responses (humoral and cell-mediated).
- Investigation of B-cell priming and memory cell generation in neonates.
- Assessment of neonatal dendritic cell function and antigen interaction.
- Evaluation of the impact of maternally derived antibodies.
Main Results:
- Neonates exhibit reduced antibody production and T-cell mediated immunity compared to adults.
- Neonatal immune responses are characterized by poor antigen presentation by dendritic cells.
- Maternal antibodies significantly impede vaccine efficacy in early life.
- Despite limitations, B-cell priming in neonates can generate memory B cells.
Conclusions:
- Early-life vaccination faces significant immunological hurdles including immaturity and maternal antibody interference.
- Novel vaccination strategies, such as sequential priming and boosting, are essential.
- These advanced strategies hold promise for inducing protective immunity in infants against infectious diseases.
Abstract:
One of the major challenges in vaccinology is the development of products that are able to induce protective immunity in the early life period. There are clear differences between adult and neonatal immune responses in both mice and humans with respect to both humoral and cell-mediated immunity. As a rule, neonates respond poorly to T-independent polysaccharide antigens and make lower and less persistent antibody responses to T-dependent protein antigens. Nevertheless, B-cell priming in neonates may lead to the generation of memory B cells. Similarly, neonatal cell-mediated immune responses are of lower potency than those generated in adults, and a key factor underlying this phenomenon may be a less effective interaction between antigen and neonatal dendritic cells. In addition to immunological immaturity in the neonate, the presence of inhibitory concentrations of maternally derived antibody imposes a further barrier to effective early life vaccination. Novel vaccination strategies including early priming and subsequent boosting are most likely to counteract these effects and provide protection from exposure to infectious disease in early life.
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines
Vaccine Production
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Microorganisms in Medicine and Therapeutics
